Liu Xudong, Tu Yanyun, Deng Xin, Liang Jian
Department of Liver Diseases, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi 530011, P.R. China.
Biomed Rep. 2014 Jan;2(1):97-100. doi: 10.3892/br.2013.201. Epub 2013 Nov 19.
This study was conducted in order to investigate whether hepatitis B surface S protein (HBs) was able to directly or indirectly promote the proliferation and expression of collagen type I (Col I) and α-smooth muscle actin (α-SMA) in hepatic stellate cells (HSCs). The LX-2 human cell line and the HepG2 human hepatocellular carcinoma cell line were employed as HSCs and as hepatocytes, respectively. Recombinant HBs was added to the LX-2 cells for 48 h and the cell proliferation was assessed by the MTT assay. Col I and α-SMA were measured in the supernatant by ELISA, following treatment of the LX-2 and/or HepG2 cells with recombinant HBs. Transforming growth factor-β1 (TGF-β1) was also determined by ELISA in the HepG2 cell supernatants. The data demonstrated that high concentrations of recombinant HBs (10-50 ng/ml) inhibited the proliferation of LX-2 cells, whereas low concentrations (0.5-5 ng/ml) did not affect LX-2 cell proliferation. After treating LX-2 cells alone with recombinant HBs for 48 h, there was no significant increase in the Col I and α-SMA levels. However, Col I was increased ~1.7-fold in co-cultured (LX-2 and HepG2) cell supernatants following treatment with HBs for 24 h (HBs vs. control group: 48.51±3.51 vs. 28.23±2.55 ng/ml, respectively). Furthermore, TGF-β1 was significantly increased in the HepG2 cell supernatants following treatment with recombinant HBs. Therefore, we concluded that HBs directly affected the proliferation of HSCs, but promoted the Col I expression in HSCs possibly by virtue of hepatocytes secreting TGF-β1. This may provide a novel explanation of the fibrogenetic mechanism induced by hepatitis B virus-related proteins.
本研究旨在调查乙肝表面S蛋白(HBs)是否能够直接或间接促进肝星状细胞(HSCs)中I型胶原蛋白(Col I)和α-平滑肌肌动蛋白(α-SMA)的增殖及表达。分别采用LX-2人细胞系和HepG2人肝癌细胞系作为肝星状细胞和肝细胞。将重组HBs添加到LX-2细胞中培养48小时,通过MTT法评估细胞增殖情况。在用重组HBs处理LX-2和/或HepG2细胞后,通过ELISA法检测上清液中的Col I和α-SMA。同时也通过ELISA法测定HepG2细胞上清液中的转化生长因子-β1(TGF-β1)。数据表明,高浓度的重组HBs(10 - 50 ng/ml)抑制LX-2细胞的增殖,而低浓度(0.5 - 5 ng/ml)则不影响LX-2细胞的增殖。单独用重组HBs处理LX-2细胞48小时后,Col I和α-SMA水平没有显著增加。然而,在用HBs处理24小时后,共培养(LX-2和HepG2)细胞上清液中的Col I增加了约1.7倍(HBs组与对照组分别为:48.51±3.51 ng/ml和28.23±2.55 ng/ml)。此外,在用重组HBs处理后,HepG2细胞上清液中的TGF-β1显著增加。因此,我们得出结论,HBs直接影响肝星状细胞的增殖,但可能通过肝细胞分泌TGF-β1促进肝星状细胞中Col I的表达。这可能为乙肝病毒相关蛋白诱导的纤维化机制提供一种新的解释。